Skip To Content

ACD/Labs Blog

Analytical data plays a critical role in R&D by supporting critical decision-making on a daily basis. Whether a synthetic chemist is looking to see if their reaction yielded the product they expected, a group of scientists in development are building an impurity control strategy, or experts in manufacturing are collecting data for regulatory submissions, applications of analytical data are ubiquitous. At a time when the volume of insight-rich data one can gather is extraordinary, chemists working in academic research, industry, and non-profit organizations alike face regular challenges in managing and sharing their data.

If you happen to be at Bio-IT World this year, be sure to stop by booth #423 to meet the ACD/Labs team and learn more about our solutions; including our new impurity profile information management solution Luminata. We’ll be busy with a number of activities in addition to networking with our fellow peers. Read on for an overview of what our team has planned for the show and where you can find us.

There is widespread agreement that going digital will help us manage data better, make us more productive, more innovative and ultimately enable us to make smarter decisions—all the way from the bench to the boardroom. Yet, we remain relatively early in the transition from paper to paperless lab, despite the need for organizations to become more innovative and more competitive.

The R&D industry has been evolving for decades to make the process of discovering new compounds and formulations in the laboratory easier and more effective. Today, innovative trends, focused predominantly around data and technology, encourage changes that aim to improve efficiencies across the industry. A couple of current trends we’re observing include open innovation (or externalization), as well as big data.

Over the course of the last four months, we have been working with Scientific Computing to publish a series of articles on a subject that we feel very passionately about (and work very close with) at ACD/Labs – the externalization of scientific research and development (read the summary here). Essentially, we used this opportunity to address some key trends specific to this topic from various perspectives in the industry. Now that the series is complete, I wanted to give you an overview of the four articles to paint a broader picture of what we, and some of our customers and partners, are seeing today.

For those of you that know me, you may be wondering why I re-joined ACD/Labs; for those that don’t know me yet, let me give you some insight into my return. When I think back on many happy firsts in my life, and I can’t not think about my career experience at the same time. And when I began to contemplate a return to ACD/Labs, the first thing that came to my mind was, of all things, Star Wars and JJ Abrams. Let me explain...